CPMS-improving patient care in Europe via virtual case discussions.

Clinical Patient Management System (CPMS) European Reference Network on Rare Endocrine Conditions (Endo-ERN) Health care inequalities Virtual consultation

Journal

Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444

Informations de publication

Date de publication:
03 2021
Historique:
received: 01 11 2020
accepted: 09 01 2021
pubmed: 3 2 2021
medline: 9 7 2021
entrez: 2 2 2021
Statut: ppublish

Résumé

The core task of European Reference Networks (ERNs) is to reduce health care inequalities throughout Europe for all patients with rare and complex conditions. A secure web-based application for virtual consultations, the Clinical Patient Management System (CPMS), was developed by the EU to provide expert specialized care for all these patients. This review analyses the opportunities and difficulties that the implementation of this virtual network implies for physicians as well as for the patients. European Reference Network on Rare Endocrine Conditions (Endo-ERN) installed an Operational Helpdesk (OH) to support their members in using CPMS. The OH initiated several actions to facilitate and increase the usage of CPMS. Satisfaction with the system and reasons for low participation rates in virtual case discussions were analyzed by different surveys. The number of CPMS users increased constantly, but the active usage of the system remains insufficient. Main reasons were technical difficulties, lack of time and insufficient awareness about CPMS in experts and patients throughout Europe. Still, outcomes of the virtual discussions are considered useful by involved experts and the discussions have provided topics for educational webinars and research. CPMS is a secure system with many advantages compared to previous ways of consulting experts but also difficulties that need to be overcome with future strategies. By facilitating its use and increasing awareness among all relevant European experts and patients, CPMS can help to make the existing expertise available for all patients with rare (endocrine) conditions throughout Europe as it was intended.

Identifiants

pubmed: 33528763
doi: 10.1007/s12020-021-02628-x
pii: 10.1007/s12020-021-02628-x
pmc: PMC7851636
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

549-554

Références

Endo-ERN: Reference Centres. https://endo-ern.eu/about/reference-centres/ (2020).
Endo-ERN: Overview of specific expertise (MTG). https://endo-ern.eu/specific-expertise/overview-mtg/ (2020).
Endo-ERN: CPMS Informed Consent Forms. https://endo-ern.eu/activities/clinical-activities-ehealth/cpms/cpms-informed-consent-forms/ (2020).
EUR-Lex: COMMISSION IMPLEMENTING DECISION (EU) 2019/1269. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32019D1269 (2019).
European Commission: ERNs and COVID-19. https://ec.europa.eu/health/ern/covid-19_en (2020).
Endo-ERN: Clinical Patient Management System. https://endo-ern.eu/activities/clinical-activities-ehealth/cpms/ (2020).
ERN Collaborative Platform: ERN Status Report September 2020. https://webgate.ec.europa.eu/ern/item/item/18366 (2020).

Auteurs

Isabel Mönig (I)

Department of Paediatrics and Adolescent Medicine, Division of Paediatric Endocrinology and Diabetes, University of Lübeck, Lübeck, Germany. isabel.moenig@uksh.de.

Danielle Steenvoorden (D)

Department of Medicine, Division of Endocrinology and Centre for Endocrine Tumors, Leiden University Medical Centre, Leiden, The Netherlands.

Johan P de Graaf (JP)

Dutch Pituitary Foundation, Nijkerk, The Netherlands.

S Faisal Ahmed (SF)

Department of Medicine, Division of Endocrinology and Centre for Endocrine Tumors, Leiden University Medical Centre, Leiden, The Netherlands.
Office for Rare Conditions, University of Glasgow, Glasgow, UK.

Domenica Taruscio (D)

National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.

Johan G Beun (JG)

Dutch Adrenal Patients Society, Nijkerk, The Netherlands.
BijnierNET/AdrenalNET, Soest, The Netherlands.

Trine H Johannsen (TH)

Department of Growth and Reproduction and International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Anders Juul (A)

Department of Growth and Reproduction and International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Olaf Hiort (O)

Department of Paediatrics and Adolescent Medicine, Division of Paediatric Endocrinology and Diabetes, University of Lübeck, Lübeck, Germany.

Alberto M Pereira (AM)

Department of Medicine, Division of Endocrinology and Centre for Endocrine Tumors, Leiden University Medical Centre, Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH